Iradimed IRMD
NASDAQ IRMD
$87.47 +0.07 (+0.08%)
At close: Aug 20, 2026 · 1:07 PM UTC

Iradimed (IRMD) Net Margin (2013 - 2026)

Iradimed (IRMD) posted quarterly Net Margin of 25.5% for Q2 2026, down 280.0% year-over-year from 14.16% in Q2 2025, and down 3.68% on a QoQ basis from 26.47% in Q1 2026.

Iradimed (IRMD) Net Margin (2013 - 2026) Analysis & Trends

Iradimed has reported Net Margin for 14 years, with the latest figure at 25.5% in Q2 2026.

  • Net Margin for Q2 2026 came in at 25.5%, down 280.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 26.62% (up 91.0% YoY), and the FY2025 annual result was 26.73%, up 142.0% from the prior year.
  • Net Margin declined to 25.5% in Q2 2026, from 26.47% in the prior quarter.
  • Over five years, Net Margin peaked at 30.7% in Q3 2023 and troughed at 17.86% in Q4 2023.
  • A 5-year average of 25.13% and a median of 25.53% in 2022 frame the typical range for Net Margin.
  • The largest YoY upside for Net Margin was 1050 bps in 2022 against a maximum downside of 807 bps in 2022.
  • A 5-year view of Net Margin shows it stood at 24.72% in 2022, then declined by 28 bps to 17.86% in 2023, then advanced by 28 bps to 22.94% in 2024, then advanced by 22 bps to 28.06% in 2025, then slipped by 9 bps to 25.5% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 25.5% in Q2 2026, 26.47% in Q1 2026, and 28.06% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 7.37%
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 19.37%
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 12.84%
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 16.67%
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 13.87%
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn 19.04%
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 10.84%
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 6.47%
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 13.47%
10 Iradimed 1.12 Bn 1.06 Bn 15.16 Mn 25.50%

Historic Data

Download Data
DateValue
Jun 30, 2026 25.50%
Mar 31, 2026 26.47%
Dec 31, 2025 28.06%
Sep 30, 2025 26.30%
Jun 30, 2025 28.29%
Mar 31, 2025 24.02%
Dec 31, 2024 22.94%
Sep 30, 2024 27.55%
Jun 30, 2024 27.34%
Mar 31, 2024 23.51%
Dec 31, 2023 17.86%
Sep 30, 2023 30.70%
Jun 30, 2023 25.91%
Mar 31, 2023 22.01%
Dec 31, 2022 25.15%
Sep 30, 2022 25.56%
Jun 30, 2022 25.48%
Mar 31, 2022 20.20%
Dec 31, 2021 36.95%
Sep 30, 2021 23.62%